CGON
CG Oncology, Inc. Common stock
NASDAQ: CGON · HEALTHCARE · BIOTECHNOLOGY
$64.75
-1.22% today
Updated 2026-04-29
Market cap
$5.70B
P/E ratio
—
P/S ratio
1,410.56x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$21 – $74
Volume
1.3M
CG Oncology, Inc. Common stock (CGON) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-13.65M | $-29.80M | $-45.68M | $-78.71M | $-132.35M |
| Capital expenditures | $97000.00 | $14000.00 | $0.00 | $234000.00 | $134000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $1.11M | $676000.00 | $1.53M | $11.40M | $26.68M |
| Free cash flow | $-13.75M | $-29.82M | $-45.68M | $-78.95M | $-132.48M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |